Skip to main content
Year archive

MAYNE PHARMA GROUP LIMITED — 2013 filings

All 32 regulatory filings released by MAYNE PHARMA GROUP LIMITED (MYX) in 2013, sourced directly from the official regulator.

32 Filings
2013 Period
2013 filings (32)
Filing Released Lang
2013 AGM Chairman's Speech 4 pages 239.9KB
AGM Information
2013-11-25 English
2013 AGM CEO's Speech 4 pages 246.4KB
AGM Information
2013-11-25 English
Results of Meeting 3 pages 321.9KB
Declaration of Voting Results & Voting Rights Announcements
2013-11-25 English
Changes to options issued 1 page 303.7KB
Share Issue/Capital Change
2013-11-25 English
Ceasing to be a substantial holder 2 pages 45.1KB
Regulatory Filings
2013-10-23 English
Notice of Annual General Meeting/Proxy Form 12 pages 1.1MB
AGM Information
2013-10-21 English
Annual Report to shareholders 86 pages 1.6MB
Annual Report
2013-09-23 English
MYX announces US agreement for Itraconazole in Cancer 3 pages 328.4KB
Capital/Financing Update
2013-09-10 English
Mayne Pharma appoints leader of USA operations 2 pages 234.6KB
Board/Management Information
2013-09-05 English
2013 Full Year Results Appendix 4E 26 pages 890.0KB
Annual Report
2013-08-26 English
2013 Full Year Results Media Release 5 pages 415.4KB
Annual Report
2013-08-26 English
2013 Full Year Results Investor Presentation 18 pages 1.2MB
Investor Presentation
2013-08-26 English
Mayne Pharma Signs European SUBACAP Distribution Agreements 2 pages 152.2KB
Capital/Financing Update
2013-08-08 English
Appendix 3B 9 pages 339.9KB
Share Issue/Capital Change
2013-07-18 English
Mayne Pharma Launches Generic Doryx 1 page 213.9KB
Regulatory Filings
2013-07-08 English
Mayne Pharma announces acquisition of Libertas 2 pages 256.0KB
M&A Activity
2013-07-01 English
Appendix 3B 9 pages 299.7KB
Capital/Financing Update
2013-07-01 English
FDA Approval of New 200mg Doryx Tablet 1 page 463.4
Regulatory Filings
2013-04-11 English
UBS Emerging Companies Conference Presentation 13 pages 1.4MB
Investor Presentation
2013-04-09 English
Ceasing to be a substantial holder 3 pages 40.1KB
Regulatory Filings
2013-03-25 English
Becoming a substantial holder 5 pages 126.7KB
Regulatory Filings
2013-03-24 English
Ceasing to be a substantial holder 2 pages 27.2KB
Regulatory Filings
2013-03-20 English
Change of Director's Interest Notice 2 pages 255.7KB
Director's Dealing
2013-03-17 English
Change in substantial holding 3 pages 35.0KB
Regulatory Filings
2013-03-14 English
Half Yearly Report and Accounts 32 pages 585.6KB
Interim / Quarterly Report
2013-02-26 English
2013 Half Year Media Release 6 pages 276.3KB
Interim / Quarterly Report
2013-02-26 English
Appendix 3B 8 pages 220.8KB
Share Issue/Capital Change
2013-02-12 English
Change of Director's Interest Notice x 3 6 pages 340.7KB
Director's Dealing
2013-02-11 English
Appendix 3B 8 pages 223.8KB
Capital/Financing Update
2013-02-07 English
Mayne Pharma Share Purchase Plan raised $5M 1 page
Capital/Financing Update
2013-02-05 English
Completion of Kapanol Acquisition 1 page 136.9KB
M&A Activity
2013-01-31 English
Share Purchase Plan 9 pages 2.5MB
Capital/Financing Update
2013-01-06 English